Skip to content

Clinical trials

Recruiting Phase 2 Leukemia, Myeloid, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2 Status: Recruiting Clear all

130 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20142
20162
20187
20193
20203
20216
20229
202311
202433
202530
202623

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting130

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center10
The First Affiliated Hospital of Soochow University7
National Cancer Institute (NCI)6
First Affiliated Hospital of Zhejiang University5
Memorial Sloan Kettering Cancer Center5
Beijing 302 Hospital4
City of Hope Medical Center4
Fred Hutchinson Cancer Center4
Masonic Cancer Center, University of Minnesota4
St. Petersburg State Pavlov Medical University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute130
Myelodysplastic Syndromes39
Precursor Cell Lymphoblastic Leukemia-Lymphoma21
Myeloproliferative Disorders19
Leukemia, Myelogenous, Chronic, BCR-ABL Positive15
Leukemia, Myelomonocytic, Chronic14
Leukemia, Biphenotypic, Acute12
Anemia, Refractory, with Excess of Blasts11
Lymphoma, Non-Hodgkin10
Leukemia9

Trials

Showing 1 to 25 of 130. Each trial links to its page on Pharma Observatory.

30 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.